NDC 10551-091 - Equagesic

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
10551-091
Package NDCs from labels
10551-091-10
Manufacturer
Mikart, Inc.
Effective date
2008-01-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
EQUAGESIC ® (meprobamate and aspirin tablets) CIVMikart, Inc.2008-01-15Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10551-091-10Equagesic100 in 1 BOTTLE, PLASTICTABLET1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10551-091EQUAGESIC (MEPROBAMATE AND ASPIRIN) TABLET [MIKART, INC.]11 package rows20080125_941E1EC2-1F14-4153-A5EA-CF7669D5EFD1.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10551-091-10EA - Each10551-091576d1bf5-9c50-44f8-b910-e446ce3d375a12013-02-13

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2E51B605-117C-6EC3-8ECC-9E4A9B1E2E95941E1EC2-1F14-4153-A5EA-CF7669D5EFD12008-01-15Warnings, Adverse reactionsExact identifier
spl id: 2E51B605-117C-6EC3-8ECC-9E4A9B1E2E95
spl set id: 941E1EC2-1F14-4153-A5EA-CF7669D5EFD1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.